BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8625279)

  • 1. Elevated protein kinase CK2 activity in chromatin of head and neck tumors: association with malignant transformation.
    Faust RA; Gapany M; Tristani P; Davis A; Adams GL; Ahmed K
    Cancer Lett; 1996 Mar; 101(1):31-5. PubMed ID: 8625279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of elevated protein kinase CK2 activity with aggressive behavior of squamous cell carcinoma of the head and neck.
    Gapany M; Faust RA; Tawfic S; Davis A; Adams GL; Ahmed K
    Mol Med; 1995 Sep; 1(6):659-66. PubMed ID: 8529132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcellular immunolocalization of protein kinase CK2 in normal and carcinoma cells.
    Faust RA; Niehans G; Gapany M; Hoistad D; Knapp D; Cherwitz D; Davis A; Adams GL; Ahmed K
    Int J Biochem Cell Biol; 1999 Sep; 31(9):941-9. PubMed ID: 10533285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense oligonucleotides against protein kinase CK2-alpha inhibit growth of squamous cell carcinoma of the head and neck in vitro.
    Faust RA; Tawfic S; Davis AT; Bubash LA; Ahmed K
    Head Neck; 2000 Jul; 22(4):341-6. PubMed ID: 10862016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.
    Cohen EE; Lingen MW; Zhu B; Zhu H; Straza MW; Pierce C; Martin LE; Rosner MR
    Cancer Res; 2006 Jun; 66(12):6296-303. PubMed ID: 16778206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase CK2 signal in neoplasia.
    Tawfic S; Yu S; Wang H; Faust R; Davis A; Ahmed K
    Histol Histopathol; 2001 Apr; 16(2):573-82. PubMed ID: 11332713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of intracellular regulation of protein kinase CK2: role of stimulus-mediated subnuclear association.
    Ahmed K; Tawfic S
    Cell Mol Biol Res; 1994; 40(5-6):539-45. PubMed ID: 7735328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear matrix proteins as malignant markers in squamous cell carcinoma of the head and neck.
    McCaffery JD; Gapany M; Faust RA; Davis AT; Adams GL; Ahmed K
    Arch Otolaryngol Head Neck Surg; 1997 Mar; 123(3):283-8. PubMed ID: 9076234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the integrin-linked kinase inhibitor QLT0267 on squamous cell carcinoma of the head and neck.
    Younes MN; Yigitbasi OG; Yazici YD; Jasser SA; Bucana CD; El-Naggar AK; Mills GB; Myers JN
    Arch Otolaryngol Head Neck Surg; 2007 Jan; 133(1):15-23. PubMed ID: 17224516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer.
    Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Traish AM; Mercurio F; Sonenshein GE
    Cancer Res; 2001 May; 61(9):3810-8. PubMed ID: 11325857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silmitasertib, a casein kinase 2 inhibitor, induces massive lipid droplet accumulation and nonapoptotic cell death in head and neck cancer cells.
    Su YW; Huang WY; Lin HC; Liao PN; Lin CY; Lin XY; Huang SH; Chen YT; Wu PS
    J Oral Pathol Med; 2023 Mar; 52(3):245-254. PubMed ID: 36273268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear matrix targeting of the protein kinase CK2 signal as a common downstream response to androgen or growth factor stimulation of prostate cancer cells.
    Guo C; Yu S; Davis AT; Ahmed K
    Cancer Res; 1999 Mar; 59(5):1146-51. PubMed ID: 10070976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase activities in neoplastic squamous epithelia and normal epithelia from the upper aero-digestive tract.
    Rydell EL; Axelsson KL; Olofsson J; Hellem S
    Cancer Biochem Biophys; 1990 Jul; 11(3):187-94. PubMed ID: 2268849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase casein kinase 2 mediates inhibitor-kappaB kinase and aberrant nuclear factor-kappaB activation by serum factor(s) in head and neck squamous carcinoma cells.
    Yu M; Yeh J; Van Waes C
    Cancer Res; 2006 Jul; 66(13):6722-31. PubMed ID: 16818647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of CK2 signaling to the nuclear matrix.
    Yu S; Wang H; Davis A; Ahmed K
    Mol Cell Biochem; 2001 Nov; 227(1-2):67-71. PubMed ID: 11827176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of autophosphorylation in regulation of protein kinase CK2 from rat neuronal chromatin.
    Kulikova OG; Reikhardt BA
    Biochemistry (Mosc); 1998 Dec; 63(12):1400-6. PubMed ID: 9916157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of protein kinase CK2 nuclear signaling in neoplasia.
    Ahmed K; Davis AT; Wang H; Faust RA; Yu S; Tawfic S
    J Cell Biochem Suppl; 2000; Suppl 35():130-5. PubMed ID: 11389542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of protein kinase CK2 with nuclear matrix: influence of method of preparation of nuclear matrix.
    Tawfic S; Davis AT; Faust RA; Gapany M; Ahmed K
    J Cell Biochem; 1997 Mar; 64(3):499-504. PubMed ID: 9057107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01.
    Amornphimoltham P; Sriuranpong V; Patel V; Benavides F; Conti CJ; Sauk J; Sausville EA; Molinolo AA; Gutkind JS
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4029-37. PubMed ID: 15217935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting CK2-driven non-oncogene addiction in B-cell tumors.
    Mandato E; Manni S; Zaffino F; Semenzato G; Piazza F
    Oncogene; 2016 Nov; 35(47):6045-6052. PubMed ID: 27041560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.